In the current study, we investigated the potential roles of a calcineurin inhibitor, tacrolimus, in the regulation of RANKL expression through the IL-6-induced JAK-STAT signaling pathway in RA FLS. Here, TNFSF11 is linked to rheumatoid arthritis.